Effectiveness of Homoeopathic medicine Arundo 30C in allergic rhinitis
Phase 2
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2023/09/057838
- Lead Sponsor
- Dr Nisha C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
_
1.Patients with clinical presentation of allergic rhinitis and raised AEC value
2.Patients of age 18-70
3.All gender categories
Exclusion Criteria
1. patients with nasal polyps, asthma, or other chronic respiratory diseases
2. Immunocompromised individuals
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the catalytic potential of Arundo 30C in allergic rhinitis patients taking homeopathic constitutional medicines <br/ ><br>2.To evaluate the effectiveness of Arundo 30C by comparing the difference in changes in total nasal symptom score & absolute eosinophil count in the study group and control group before and after treatment. <br/ ><br>Timepoint: Base line and three months
- Secondary Outcome Measures
Name Time Method To compare the improvement in the quality of life of patients in both study & control groupsTimepoint: base line & three months